ATRA
- Atara Biotherapeutics, Inc.
()
Overview
Company Summary
Atara Biotherapeutics, Inc. is a biopharmaceutical company that focuses on developing innovative therapies for patients with serious medical conditions. Their main area of expertise lies in the fields of immunotherapy and cellular therapy. Atara is dedicated to addressing unmet medical needs by harnessing the power of the immune system to target and destroy diseases.
The company's primary focus is on developing off-the-shelf, allogeneic T-cell immunotherapies. These therapies involve using T-cells, which are a type of white blood cell that plays a crucial role in the immune system's response to invaders like viruses or cancer cells. Atara's approach involves modifying these T-cells in the lab and reinfusing them into patients to enhance their ability to identify and destroy disease cells.
One of Atara's most notable projects is developing therapies for the treatment of cancer. They are currently working on a range of immunotherapies that target specific types of cancer, including hematologic malignancies such as lymphoma and leukemia.
Additionally, Atara is exploring the use of immunotherapies to treat viral infections, such as respiratory syncytial virus (RSV) and Epstein-Barr virus (EBV), which can cause serious complications in immunocompromised patients.
Overall, Atara Biotherapeutics is a company at the forefront of leveraging the potential of the immune system to develop novel therapies for various diseases, with a particular focus on cancer and viral infections.